Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of nalmefene pre-injection in painless gastrointestinal endoscopy
ChiCTR2400088347Phase 4Not yet recruiting
- Sponsor
- Taizhou Fourth People's Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalmefene in None (3 arms), sponsored by Taizhou Fourth People's Hospital. Primary endpoint: Incidence of respiratory depression during painless examination. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
nalmefene
Beyond the preview
Go deeper on ChiCTR2400088347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088347.